Family History
455 articles
Just Continue to Fight
Roberta Luna has been fighting pancreatic cancer for 15 years. She lost both her parents, her uncle, and her grandmother to the disease but she keeps on fighting.
Going Outside Standard Protocol Changed Everything
Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Diagnosed Early
Because Anthony Rafaniello had recurring pancreatitis, he paid close attention when he started to feel sick. The result: pancreatic cancer diagnosed early.
Tumor Staging and Pancreatic Cancer
What is tumor staging and how does it affect treatment? Dr. Shubham Pant helps explain how pancreatic cancer tumors are staged and graded.
Important Questions When Starting Pancreatic Cancer Treatment
Dr. Gauri Varadhachary outlines the important questions to ask when you start treatment with surgery, chemotherapy, or radiation for pancreatic cancer.
Our Destiny Is Not in the Data
With a young family, Yann Bizien was determined to be a survivor of stage IV pancreatic cancer, even after a recurrence.
Treating Cancer By Mutation, Not by Tumor Location
Dr. Conan Kinsey outlines the latest basket trials, which focus on tumor mutation, not the location of the cancer.
Highlights from the 2025 AACR Annual Meeting
Drugs to target KRAS, better imaging for earlier detection, and cachexia prediction are among the research highlights from AACR 2025.
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.